Cornelia Landersdorfer

Projects

Projects per year 2011 2013 2014 2015 2016 2019 2020 2023 2028

• 4 Active
• 18 Finished

Projects per year

Search results

• Active

  Bridging the gap between urinary tract infection pharmacokinetic/pharmacodynamic in vitro models and the optimization of antibiotic selection, dosing strategies, clinical breakpoints, and novel drug development

  Abbott, I., Peleg, A., Landersdorfer, C., Bradshaw, C., Meletiadis, J., Huttner, A. & Patel, R.

  United States Food and Drug Administration

  29/09/23 → 28/09/26

  Project: Research

• MMQPA: Monash-Moderna Quantitative Pharmacology Accelerator

  Kirkpatrick, C., Landersdorfer, C. & Porter, C.

  Monash University – Internal University Contribution

  15/08/23 → 14/08/28

  Project: Research

• Centre of Research Excellence - REduce the burden of antimicrobial reSistance through oPtimal, persONalised Dosing (RESPOND)

  Roberts, J. A., Slavin, M. A., Paterson, D. L., Comans, T. A., Lipman, J., Landersdorfer, C., Joynt, G., Bellomo, R., Clark, J. & Parker, S. L.

  1/01/22 → 31/12/26

  Project: Research

• Developing an integrated approach to precision medicine targeting antimicrobial resistance of bacterial 'superbugs'

  Landersdorfer, C., Oliver, A. & Nation, R.

  National Health and Medical Research Council (NHMRC) (Australia)

  1/01/20 → 31/12/24

  Project: Research

• Finished

  Defining target penicillin concentrations for Animal Studies of a Reformulated Long-Acting Benzathine Penicillin Prototype

  Carapetis, J. R., Kado, J., Barnett, T. C., Landersdorfer, C., Boyd, B., Sullivan, M. & Spector, J.

  4/02/20 → 30/09/20

  Project: Research

• Antibacterial Material Design via Mechanism-Based Mathematical Modelling

  Whittaker, M., Landersdorfer, C. & Velkov, T.

  31/01/20 → 31/12/23

  Project: Research

• The development of novel pharmacokinetic techniques to optimise treatment and reduce antimicrobial resistance for sexually transmitted infections (STIs).

  Kong, F. Y. S., Hocking, J. S., Unemo, M., Fairley, C., Landersdorfer, C., Williamson, D. A., Roberts, J. A., Wallis, S. & Parker, S. L.

  National Health and Medical Research Council (NHMRC) (Australia)

  1/01/20 → 31/12/22

  Project: Research

• Overcoming multidrug-resistant hypermutable Pseudomonas aeruginosa via antibiotic combinations

  Landersdorfer, C., Oliver, A., Harper, M. & Nation, R.

  National Health and Medical Research Council (NHMRC) (Australia)

  1/01/19 → 31/12/23

  Project: Research

• Combating Pseudomonas aeruginosa infections in paediatric patients with cystic fibrosis

  Landersdorfer, C., Deveson, D., Boyce, J., Nation, R. & Oliver, A.

  1/01/19 → 31/12/19

  Project: Research

• Novel dosing regimens to maximise antibiotic effectiveness for treatment of pneumonia in the intensive care unit

  Roberts, J. A., Lipman, J., De Waele, J., Koulenti, D. & Landersdorfer, C.

  National Health and Medical Research Council (NHMRC) (Australia)

  1/01/19 → 31/12/23

  Project: Research

• Pharmacokinetic and Pharmacodynamic Support to Emmes under Clinical Research in Infectious Disease (CRID) Contract with National Institute of Allergy and Infectious Diseases (RFP CRID-2016-01)

  Landersdorfer, C., Kirkpatrick, C. & Yadav, R.

  10/01/17 → 28/02/17

  Project: Research

• SPEX 6870 Freezer Mill

  Kong, D., Landersdorfer, C., Lee, W. L., Choong, P. F. M. & Peel, T.

  Equity Trustees - Trustee for Harold and Cora Brennen Benevolent Trust

  1/01/16 → 31/12/16

  Project: Research

• Targeting hypermutable 'superbugs' in chronic respiratory infections by optimised antibiotic combination dosage regimens

  Landersdorfer, C., Boyce, J., Bulitta, J., Nation, R. & Oliver, A.

  National Health and Medical Research Council (NHMRC) (Australia)

  1/01/16 → 31/12/19

  Project: Research

• Centre for REdefining antibiotic use to reDUce resistanCE and prolong the lives of antibiotics (REDUCE)

  Roberts, J. A., Lipman, J., Peake, S., Turnidge, J. D., Slavin, M. A., Hopkins, P. M. A., Landersdorfer, C., Paul, S. K., De Waele, J., Joynt, G. & Udy, A.

  1/12/15 → 30/11/20

  Project: Research

• Perturbation of the extracellular architecture to promote the absorption and lymphatic transport of biologicalmacromolecules

  Porter, C., Kaminskas, L., Landersdorfer, C., McIntosh, M. & Keller, G.

  Australian Research Council (ARC), Halozyme Therapeutics Inc

  6/01/15 → 31/12/18

  Project: Research

• Combating hypermutable 'superbugs' by innovative antibiotic combinations

  Landersdorfer, C.

  ANZ Executors and Trustee Company Ltd.

  1/01/15 → 31/12/15

  Project: Research

• Identification of the pharmacokinetic/ harmacodynamic (PK/PD) index and targets of fosfomycin for bacterial killing and prevention of resistance against multidrug - resistant Pseudomonas aeruginosa.

  Bergen, P., Landersdorfer, C. & Peleg, A.

  Australian Society for Antimicrobials

  1/01/15 → 31/12/15

  Project: Research

• Dosing to maximise bacterial killing and prevent resistance in ICU

  Kirkpatrick, C., Bergen, P., Landersdorfer, C. & Wirth, H.

  National Health and Medical Research Council (NHMRC) (Australia)

  1/01/14 → 31/12/16

  Project: Research

• Combating bacterial 'superbugs' by innovative antibiotic combination strategies

  Landersdorfer, C.

  National Health and Medical Research Council (NHMRC) (Australia)

  1/01/14 → 31/12/17

  Project: Research

• Two FibreCell Duet Pumps & Two Masterflex pumps L/S

  Bulitta, J., Bergen, P., Landersdorfer, C., Li, J. & Nation, R.

  Collier Charitable Fund

  1/01/13 → 30/09/13

  Project: Research

• Combating bacterial 'superbugs' by innovative dosing strategies that combine available antibiotics to prevent resistance

  Landersdorfer, C., Boyce, J., Bulitta, J. B. B., Kirkpatrick, C., Nation, R., Oliver, A. & Velkov, T.

  National Health and Medical Research Council (NHMRC) (Australia)

  1/01/13 → 31/12/16

  Project: Research

• Pharmacometrics - Modelling and Simulation Services

  Kirkpatrick, C., Bulitta, J. & Landersdorfer, C.

  12/09/11 → 16/02/12

  Project: Research